Commercialisation firm the IP Group extends agreement with Manchester to include funding for graphene products.
The IP Group has extended its commercialisation agreement with the University of Manchester’s tech transfer unit UMI3 to include proof-of-principle funding for graphene products. The UK-based commercialisation firm has also announced that it is adding a further £2.5m ($4.13m) to the agreement’s backing, bringing its total to £7.5m. Manchester, the university which first isolated graphene…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
